HealthVerity Discusses COVID-19, Booster Vaccines, and RWD
As variants of the COVID-19 virus emerge, included the concerning delta variant, pharmaceutical companies are suggesting that a booster shot [...]
Biogen Unsuccessful in ICER Attack as Aduhelm Controversy Continues
Biogen has attempted to shield itself from the Institute for Clinical and Economic Review (ICER)’s objections to its Alzheimer’s drug, [...]
Voters Seek to Maintain Access to Medication Through Medicare
A recent poll showed that voters strongly support access to prescription drugs through Medicare Part D. In addition, voters are [...]
A Brief History of Pharmacy Benefit Managers (How They Became the “Shady Middle Men” in the Drug Market)
This is a guest post by Taylor J. Christensen, M.D. (@taylorjayc). Dr. Christensen is an internal medicine physician and health [...]
CrossBridge Health Acquires Geisinger-developed PACER Software
Geisinger’s Patient Centric Electronic Redesign (PACER) patient monitoring and clinical workflow software has been acquired by CrossBridge Health , a [...]
Reducing Administrative Costs in US Health Care: Assessing Single Payer and Its Alternatives
The following guest post is by David Scheinker, Barak Richman, Arnold Milstein, and Kevin Schulman. Administrative costs in the US [...]
Model Estimates Little Impact on US Payer Budgets by the Use of Selinexor, Bortezomib, Dexamethasone in Previously-Treated Multiple Myeloma
According to the results of a study published in ClinicoEconomics and Outcomes Research, the introduction of selinexor, bortezomib, and dexamethasone [...]
OptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients Seite 1
OptimizeRx’s AI-driven platform leverages real-world evidence (RWE) to support doctors in their efforts to maintain patient treatment plans ROCHESTER, Mich., [...]
Radar on Market Access: Zeposia May Have Challenges Within Ulcerative Colitis Class
On May 27, the FDA gave an additional indication to Bristol Myers Squibb’s Zeposia (ozanimod) for the treatment of adults [...]
Amalgam Rx™ and AWS Collaborate to Accelerate and Simplify Healthcare Innovation
Amalgam Rx™ and AWS Collaborate to Accelerate and Simplify Healthcare Innovation Amalgam Rx™ and AWS Collaborate to Accelerate and Simplify [...]
FDA Approves New Use of Transplant Drug Based on Real-World Evidence
FDA Approves New Use of Transplant Drug Based on Real-World Evidence Today, the U.S. Food and Drug Administration approved a [...]
Clinical Trial Market Global Forecast, Impact of COVID-19, Industry Trends by Phases, Study Design, Region, Opportunity Company Overview, Revenue
The clinical trial is a human medical study designed to test the safety and effectiveness of drugs, therapeutic products and [...]
NICE Upholds Rejection of Expensive Cancer Drug as Calls for Flexible Drug Pricing Models Grow
The National Institute for Health and Care Excellence (NICE) has rejected Zytiga for the second time. Despite evidence that the [...]
Kadmon eyes $15.5K pricetag and August debut for new transplant rejection med Rezurock
Kadmon eyes $15.5K pricetag and August debut for new transplant rejection med Rezurock. To see the mission through, the company [...]
New Report Notes 65 Prescription Drug Increases in July 2021, 800 in January
65 drugs have increased in price this month by approximately 3.5%. GoodRx identified drug manufacturers, which include Pfizer, Bristol Myers [...]
Six Guiding Principles for the Design and Use of Artificial Intelligence in Health Care | Published by Journal of Health Economics and Outcomes Research
RT @JournalHEOR: Six Guiding Principles for the Design and Use of Artificial Intelligence in Health Care: https://t.co/H5XRUGQqaE #healthc… Read the [...]
ISPOR’s Flagship Journal Value in Health Demonstrates High Impact
Newswise — Lawrenceville, NJ, USA—July 13, 2021—New data released by Clarivate’s Journal Citation Reports fortifies ISPOR’s premier journal, Value in [...]
The growing scope of Medical Affairs in an evolving ecosystem
The growing scope of Medical Affairs in an evolving ecosystem Health Industry Hub | July 14, 2021 | [Total: 1 [...]
More than 800 medicines are in development for diseases that disproportionately affect racial and ethnic communities
We are in a new era of medicine where groundbreaking biopharmaceutical research and development is transforming medicine, but these innovations [...]
Building a better health care system: A conversation with Mark Reisenauer, President of Astellas US
Our industry continues to work tirelessly to combat the COVID-19 virus by developing effective therapeutics to treat COVID-19 and vaccines [...]
Here’s Why 2 Major Health Centers Won’t Carry Controversial New Alzheimer’s Drug
Two of the nation’s most influential health systems have said they won’t administer Biogen’s Aduhelm, a controversial new Alzheimer’s treatment [...]
Journal round-up: PharmacoEconomics 39(5) – The Academic Health Economists’ Blog
Our authors provide regular round-ups of the latest peer-reviewed journals. We cover all issues of major health economics journals as [...]
Promoting global vaccine equity while protecting innovation
America’s biopharmaceutical companies have successfully researched, developed and distributed billions of doses of multiple vaccines and therapeutics to halt the [...]
After 10,000% price hike, pharma companies face $350M+ fine in UK
After 10,000% price hike, pharma companies face $350M+ fine in UK esagonowsky Thu, 07/15/2021 - 09:47 Read the source article [...]
Takeda, AbbVie, BMS, Sanofi, Lilly and others join growing tally of pharma’s July price hikes: report
Takeda, AbbVie, BMS, Sanofi, Lilly and others join growing tally of pharma's July price hikes: report nhigginsdunn Thu, 07/15/2021 - [...]